Responding to an FDA Form 483 or warning letter

Form FDA 483

At the end of an inspection the FDA presents Form 483 to senior management and discusses it ¹. It notifies management of objectionable conditions. Companies are encouraged to respond in writing with a corrective action plan and carry it out quickly ¹. The form is not a final agency determination. The FDA weighs it with the establishment inspection report, evidence collected and any company response ¹.

The FDA publishes spreadsheets of areas of regulation cited on system-generated 483s by fiscal year, from FY 2006 to FY 2025 ⁵. The agency says these are not a full list, as some 483s are prepared by hand ⁵.

The warning letter

Chapter 4 of the Regulatory Procedures Manual says warning letters are issued to achieve voluntary compliance and to establish prior notice ². A warning letter communicates the agency's position but does not commit the FDA to enforcement action ². The FDA has no legal obligation to warn before taking enforcement action ².

The letter includes a request for correction and a written response within a set period, usually 15 working days after receipt ². The FDA's public page says the letter gives the recipient a chance to address the concerns. A recipient who disagrees can supply its reasoning and supporting information ³.

Internal FDA timelines

If a Form 483 response arrives during legal review of a draft letter, the review clock stops and restarts once counsel receives the response and the program's assessment ².

Who receives a letter

Warning letters go to the party responsible for the violation, and the issuing office must identify that party first ². The FDA may write to importers, owners or consignees of regulated imports. A letter to a customs broker is not usually appropriate, except where the broker is itself the owner, consignee or importer, or has authority over the product ². A foreign firm may receive one where the FDA has regulatory authority over it and is prepared to use it ².

A second warning letter for the same or similar violations should not usually be issued, though the manual allows one in some situations to establish prior notice ². If violations are seen at a later inspection, the FDA says enforcement action may follow without further notice ³.

Close-out and publication

A close-out letter is not issued on promises. The corrections must be made and verified, usually by a follow-up inspection ³. No close-out letter issues where the violations cannot be corrected ³. The programme applies to warning letters issued on or after 1 September 2009 ³.

Warning letters are posted on fda.gov. The FDA removes them only if it rescinds or amends them ². A recipient may ask the FDA to post its response, which is redacted under the Freedom of Information Act before posting ². The FDA warning letter database can be filtered for letters with response or close-out letters ⁴. The FDA notes that later contact may have changed the status of matters in a letter ⁴.